SCHEMBL22010823

SCHEMBL22010823

CCCCCC1CCC(CCc2cc3oc4cc(OCC)c(F)c(F)c4c3c(F)c2F)CO1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22011229 0.90
SCHEMBL22011197 0.89
SCHEMBL22011204 0.88 EPHX1 (0.33) EPHX1
SCHEMBL22011129 0.82 EPHX1 (0.31) EPHX1
SCHEMBL22010812 0.81 EPHX1 (0.32) EPHX1
SCHEMBL22010822 0.81 PGAM1 (0.33)
SCHEMBL20102471 0.79 SLC6A2 (0.32)
SCHEMBL22010791 0.79 RIPK1 (0.30)
SCHEMBL22010811 0.79 KDM4E (0.36)
SCHEMBL22010964 0.77 KDM4E (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device YBX1, ZKSCAN2, RCC1 EPHX1 948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.